Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Bacau – page 3

48 clinical trials in Bacau, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Bacau at a glance
48
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

48 trials in Bacau

Open in trial search

Obesity

Not recruiting

A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Berobenatide
  • Sponsor:Metsera Inc.

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Roflumilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Asthma

Not recruiting

Study of rocatinlimab compared to placebo to help adults with Moderate to Severe Asthma

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate Anhydrous
  • Sponsor:Chiesi Farmaceutici S.p.A.

Systemic scleroderma

Not recruiting

Study on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:BI 685509
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Atrial fibrillation

Not recruiting

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational
Countries:RomaniaRomania
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Asthma

Not recruiting

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.

Breast cancer+3

Not recruiting

Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Romiplostim
  • Sponsor:Amgen Inc.

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Obesity+1

Not recruiting

A study testing cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Bacau

What the registry says about research in the country

01 Respiratory Diseases

Innovative trials focusing on respiratory conditions, including studies evaluating new treatments for asthma and COPD. Research aims to improve lung function and reduce disease exacerbations.

  • Asthma management studies
  • COPD treatment evaluation
  • Lung function improvement research

Multiple trials investigating both established and novel therapeutic approaches for better respiratory care.

02 Metabolic Disorders

Comprehensive research into Type 2 Diabetes and obesity, examining innovative therapeutic combinations and their impact on cardiovascular outcomes.

  • Diabetes management strategies
  • Weight management interventions
  • Cardiovascular risk reduction

Studies focus on dual benefits of treatments addressing both diabetes and weight management.

03 Autoimmune Conditions

Advanced research into rheumatoid arthritis, systemic sclerosis, and other inflammatory conditions, testing new biological therapies and treatment combinations.

  • Arthritis treatment comparisons
  • Inflammatory disease management
  • Biological therapy evaluation

Investigations aim to improve quality of life for patients with chronic inflammatory conditions.

04 Cardiovascular Health

Studies focusing on heart failure prevention and cardiovascular risk reduction, evaluating novel therapeutic approaches and combination treatments.

  • Heart failure prevention
  • Cardiovascular risk management
  • Therapeutic combinations

Research aims to reduce cardiovascular events and improve patient outcomes.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.